Login
TARE & liver cancer · Expert video

Long-Term Considerations After Y-90 Treatment

An overview of longer-term considerations after Yttrium-90 treatment and the role of follow-up in patients receiving liver-directed radioembolisation.

Presented byDr. Ishita B. SenDepartment of Nuclear Medicine, FMRI · Recorded 2021
Expert explainer · English/Hindi as recordedA complete transcript is available below.

Read the discussion

Y90 or Yttrium 90 is a very potent radioisotope which is used to treat liver tumors and this may be labeled with a spheres and which are used in patients with Hepatocellular carcinoma or in certain metastasis sometimes also in neuroendocrine tumors or they may be labeled with somatostatin receptor analog like dotatoc or dotatate and in such situation, this is called Y90 PRRT. Now Y90 PRRT may be used either by itself or it may be used along with Lutetium Therapy in alternating kind of protocol so you give one dose of Lutetium PRRT followed by a dose of Y90 again followed by Lutetium Therapy along with next dose as Y90. So this is called Tandem Therapy and this is very effective in patients who’ve got a large volume diseases. 

Note: The content provided on this video is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Medical information notice: This video is educational and does not replace an individual consultation. Treatment suitability depends on current imaging, pathology, prior therapy, organ function and multidisciplinary clinical review.

Expert library

Explore all nuclear medicine videos.

More explainers on prostate cancer, PRRT, TARE and radioligand science.

View all 15 videos

Medical disclaimer All physicians and researchers profiled on this page hold appointments at the Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute, Gurugram. Theranostic Physicians Private Limited (TPPL) is the clinical practice entity through which they consult and treat patients. Treatment outcomes vary by individual case; clinical decisions are made on the basis of complete medical records, current imaging, and a multidisciplinary review.